ArticleFrontiers in public health2025
Confronting the public health challenge of inaccessible COVID-19 home tests: insights from the RADx® Tech Accessibility Initiative.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
COVID-19 home tests first distributed by the U.S. Government in early 2022 proved inaccessible to Americans with no vision, low vision, limited dexterity, and certain aging-related impairments. The National Institute of Biomedical Imaging and Bioengineering (NIBIB) leveraged a multimillion-dollar investment to address this challenge via the Rapid Acceleration of Diagnostics (RADx®) Tech Accessibility Initiative. What follows is a case study report on the March 2022-June 2023 implementation of this initiative, which was later expanded into a larger-scale program called RADx Tech III (September 2022-present). The initiative unveiled a substantial gap in resources guiding accessible product development and applied crisis response funding to bridge this gap. Beyond the primary goal of improving accessibility of COVID-19 home tests, the initiative was successful in developing an expert resource pool, documenting best practices for design of accessible home tests, and generating/validating a framework for future accessibility initiatives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.